| Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low … Z Onódi, T Visnovitz, B Kiss, S Hambalkó, A Koncz, B Ágg, B Váradi, ... Journal of Molecular and Cellular Cardiology 165, 19-30, 2022 | 109 | 2022 |
| Characterization of immune checkpoint inhibitor‐induced cardiotoxicity reveals interleukin‐17A as a driver of cardiac dysfunction after anti‐PD‐1 treatment TG Gergely, D Kucsera, VE Tóth, T Kovács, NV Sayour, ZD Drobni, ... British Journal of Pharmacology 180 (6), 740-761, 2022 | 61 | 2022 |
| Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure TG Gergely, ZD Drobni, M Kallikourdis, H Zhu, WC Meijers, TG Neilan, ... Nature Reviews Cardiology 21 (7), 443-462, 2024 | 41 | 2024 |
| Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors TG Gergely, ZD Drobni, NV Sayour, P Ferdinandy, ZV Varga Basic Research in Cardiology 120 (1), 187-205, 2025 | 34 | 2025 |
| Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion GB Brenner, A Makkos, CT Nagy, Z Onódi, NV Sayour, TG Gergely, B Kiss, ... Cells 9 (3), 551, 2020 | 30 | 2020 |
| Post-myocardial infarction heart failure in closed-chest coronary occlusion/reperfusion model in Göttingen minipigs and landrace pigs GB Brenner, Z Giricz, R Garamvölgyi, A Makkos, Z Onódi, NV Sayour, ... J. Vis. Exp 170, e61901, 2021 | 23 | 2021 |
| IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH D Kucsera, VE Tóth, NV Sayour, T Kovács, TG Gergely, M Ruppert, ... Scientific Reports 13 (1), 356, 2023 | 19 | 2023 |
| Cardioprotective efficacy of limb remote ischaemic preconditioning in rats: discrepancy between a meta-analysis and a three-centre in vivo study NV Sayour, GB Brenner, A Makkos, B Kiss, C Kovácsházi, TG Gergely, ... Cardiovascular Research 119 (6), 1336-1351, 2023 | 16 | 2023 |
| Saxagliptin cardiotoxicity in chronic heart failure: The role of DPP4 in the regulation of neuropeptide tone I Vörös, Z Onódi, VE Toth, TG Gergely, É Sághy, A Görbe, Á Kemény, ... Biomedicines 10 (7), 1573, 2022 | 13 | 2022 |
| Reduced circulating CD63+ extracellular vesicle levels associate with atherosclerosis in hypercholesterolaemic mice and humans BM Kestecher, K Németh, S Ghosal, NV Sayour, TG Gergely, BR Bodnár, ... Cardiovascular Diabetology 23 (1), 368, 2024 | 12 | 2024 |
| The changes in the pharmacotherapy of heart failure with reduced ejection fraction and its effect on prognosis: experience in the Hungarian clinical practice B Muk, D Pilecky, F Bánfi-Bacsárdi, T Füzesi, GT Gergely, A Komáromi, ... Orvosi hetilap 165 (18), 698-710, 2024 | 11 | 2024 |
| Effect of hypercholesterolemia on circulating and cardiomyocyte-derived extracellular vesicles C Kovácsházi, S Hambalkó, NV Sayour, TG Gergely, GB Brenner, ... Scientific Reports 14 (1), 12016, 2024 | 9 | 2024 |
| Droplet Digital PCR Is a Novel Screening Method Identifying Potential Cardiac G-Protein-Coupled Receptors as Candidate Pharmacological Targets in a Rat Model of Pressure … NV Sayour, VÉ Tóth, RN Nagy, I Vörös, TG Gergely, Z Onódi, N Nagy, ... International Journal of Molecular Sciences 24 (18), 13826, 2023 | 9 | 2023 |
| Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In Vivo BY Weber, GB Brenner, B Kiss, TG Gergely, NV Sayour, H Tian, A Makkos, ... Pharmaceuticals 15 (9), 1055, 2022 | 9 | 2022 |
| Comparison of mouse models of heart failure with reduced ejection fraction NV Sayour, TG Gergely, B Váradi, VÉ Tóth, B Ágg, T Kovács, D Kucsera, ... ESC Heart Failure 12 (1), 87-100, 2025 | 8 | 2025 |
| IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): a small animal acute myocardial infarction randomized-controlled multicenter study on the effect of … S Hernandez-Resendiz, R Vilskersts, D Aluja, I Andreadou, P Bencsik, ... Basic Research in Cardiology 120 (2), 335-346, 2025 | 6 | 2025 |
| The role of complex patient education program in heart failure care F Bánfi-Bacsárdi, EM Boldizsár, GT Gergely, Z Forrai, Á Kazay, T Füzesi, ... Orvosi hetilap 165 (37), 1461-1471, 2024 | 6 | 2024 |
| Rapid up-titration of guideline-directed medical therapy after a heart failure hospitalisation GT Gergely, F Bánfi-Bacsárdi, A Komáromi, D Pilecky, EM Boldizsár, ... Orvosi hetilap 165 (31), 1197-1205, 2024 | 6 | 2024 |
| Therapeutic Consequences and Prognostic Impact of Multimorbidity in Heart Failure: Time to Act F Bánfi-Bacsárdi, Á Kazay, TG Gergely, Z Forrai, TP Füzesi, LF Hanuska, ... Journal of Clinical Medicine 14 (1), 139, 2024 | 5 | 2024 |
| Effects of sex and obesity on immune checkpoint inhibition-related cardiac systolic dysfunction in aged mice NV Sayour, D Kucsera, AR Alhaddad, VÉ Tóth, TG Gergely, T Kovács, ... Basic Research in Cardiology 120 (1), 207-223, 2025 | 4 | 2025 |
